Overview

Clinical Study Evaluating Efficacy, Safety and Molecular Mechanism of N-acetylcysteine Supplementation in Patients With Hepatic and Post Hepatic Jaundice

Status:
COMPLETED

Trial end date:
2025-01-22

Target enrollment:

Participant gender:

Summary

Investigating the efficacy, safety, and molecular mechanism of N-acetylcysteine supplementation in improving elevated direct bilirubin level and liver function tests in patients with hepatic and post-hepatic jaundice.

Phase:

PHASE2

Details

Lead Sponsor:

Tanta University

Treatments:

Acetylcysteine